(Q57655200)

English

Similar lymphocyte recovery and CMV reactivation profiles between reduced intensity conditioning with alemtuzumab and myeloablative allogeneic stem cell transplantation

No description defined

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Similar lymphocyte recovery and CMV reactivation profiles between reduced intensity conditioning with alemtuzumab and myeloablative allogeneic stem cell transplantation (English)

0 references

stem cell transplantation

1 reference

based on heuristic

inferred from title

author name string

Q A Hill

1

0 references

A Hill

2

0 references

T A Collyns

3

0 references

R M Pearce

4

0 references

G Cook

5

0 references

language of work or name

0 references

publication date

14 January 2008

0 references

Bone Marrow Transplantation

0 references

41

0 references

8

0 references

749-751

0 references

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705974

7 January 2021

based on heuristic

inferred from DOI database lookup

CMV infection following nonmyeloablative allogeneic stem cell transplantation using Campath

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705974

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of CAMPATH-1H in BMT patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705974

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705974

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705974

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705974

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705974

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune reconstitution at 6 months following T-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705974

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705974

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705974

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57655200&oldid=2213574921"